| Literature DB >> 25848588 |
Kim N Danforth1, Andrea E Smith1, Ronald K Loo1, Steven J Jacobsen1, Brian S Mittman1, Michael H Kanter1.
Abstract
Efforts to improve patient safety have largely focused on inpatient or emergency settings, but the importance of patient safety in ambulatory care is increasingly being recognized as a key component of overall health care quality. Care gaps in outpatient settings may include missed diagnoses, medication errors, or insufficient monitoring of patients with chronic conditions or on certain medications. Further, care gaps may occur across a wide range of clinical conditions. We report here an innovative approach to improve patient safety in ambulatory settings - the Kaiser Permanente Southern California (KPSC) Outpatient Safety Net Program - which leverages electronic health information to efficiently identify and address a variety of potential care gaps across different clinical conditions. Between 2006 and 2012, the KPSC Outpatient Safety Net Program implemented 24 distinct electronic clinical surveillance programs, which routinely scan the electronic health record to identify patients with a particular condition or event. For example, electronic clinical surveillance may be used to scan for harmful medication interactions or potentially missed diagnoses (e.g., abnormal test results without evidence of subsequent care). Keys to the success of the program include strong leadership support, a proactive clinical culture, the blame-free nature of the program, and the availability of electronic health information. The Outpatient Safety Net Program framework may be adopted by other organizations, including those who have electronic health information but not an electronic health record. In the future, the creation of a forum to share electronic clinical surveillance programs across organizations may facilitate more rapid improvements in outpatient safety.Entities:
Keywords: ambulatory care; electronic clinical surveillance; electronic health information; electronic health record (EHR); outpatient care; quality improvement
Year: 2014 PMID: 25848588 PMCID: PMC4371433 DOI: 10.13063/2327-9214.1056
Source DB: PubMed Journal: EGEMS (Wash DC) ISSN: 2327-9214
24 Electronic Clinical Surveillance Programs Implemented through the Outpatient Safety Net Program to Improve Ambulatory Care Safety and Quality
|
| ||
| Cervical Cancer - Pap Smear | Improve timely follow-up | |
| Colorectal Cancer – Fecal Immunochemical Tests (FIT) | Improve timely follow-up | |
| Colorectal Cancer – Colonoscopy | Increase use of colonoscopy among members with (presumed) iron deficiency anemia or a history of rectal bleeding, and without a colonoscopy in the past 10 years. | |
| Prostate Cancer – Prostate-Specific Antigen (PSA) | Improve timely follow-up | |
| Chronic Kidney Disease -- Creatinine | Increase repeat creatinine testing within 90 days of an initial abnormal creatinine result to facilitate prompt diagnosis of Chronic Kidney Disease (CKD). | |
| Hepatitis C Virus Infection | Improve timely follow-up | |
|
| ||
|
| ||
| | ||
| Amiodarone + Simvastatin | Minimize safety risks by medication conversion. | |
| Gemfibrozil + any Statin | Minimize rhabdomyolysis risk by converting or stopping medications. | |
| | ||
| Dementia + Antidepressants | Reduce drug-disease interactions through medication conversion. | |
| Falls + Antidepressants or Sleep Medications | Reduce drug-disease interactions through medication conversion. | |
| ACE/ARBs + Diuretics | Increase annual monitoring (electrolytes and serum creatinine). | |
| Anticonvulsants | Increase annual monitoring (drug levels). | |
| Digoxin | Increase annual monitoring (potassium and serum creatinine). | |
| Amiodarone | Improve follow-up of abnormal lab results to monitor for liver, thyroid, or pulmonary toxicity. | |
| Overdue Labs in Primary Care | Increase the number of completed labs via patient reminder letters regarding labs more than 30 days overdue. | |
| ACE/ARB candidates | Increase appropriate hypertension medication use among members with diabetes. | |
| Acetaminophen (APAP) | Decrease overuse of acetaminophen for members taking >4gm daily by converting prescription or referring to pain management clinics. | |
| Digoxin Dose Adjustment | Decrease potential for toxicity. | |
|
| ||
|
| ||
| Abdominal Aortic Aneurysm (AAA) | Improve care by (1) point-of-care screening reminders, (2) follow-up based on clinical practice guidelines, and (3) tracking to improve timely referral to radiology or vascular surgery. | |
| Chronic Kidney Disease (CKD) Progression | Identify members with rapid deterioration of renal function to ensure timely and appropriate follow-up. | |
| Chlamydia Infection | Improve timely follow-up of positive chlamydia tests. | |
| Newborn Hearing Screen | Ensure timely and appropriate follow-up of a failed hearing screening among newborns. | |
| Post Splenectomy Immunization | Increase vaccinations among asplenia patients missing one or more recommended immunizations. | |
| Unintended Pregnancy Follow-up | Increase birth control counseling following an elective termination of pregnancy. | |
TSH = thyroid-stimulating hormone
The definition of “timely follow-up” varies by the type of care gap being targeted by the Safety Net Program, and is jointly determined by leadership, clinicians, and other care providers.
Combined into a single medication monitoring tool at the end of 2012.
Figure 1.Process for Developing and Launching New Electronic Clinical Surveillance Programs through the Outpatient Safety Net Program
Criteria Used by KPSC Leadership to Assess Potential Topics for Outpatient Safety Net Program
| Will it improve patient safety or quality? If yes, – How many people will be affected? – What is the severity of the potential safety gap? | |
| Is the potential safety gap readily identifiable using existing electronic health data? That is: – Is the information required discretely coded? (e.g., captured by diagnostic or procedure codes, pharmacy data) – If the information required is not discretely coded, is it noted consistently in a way that makes natural language processing a reasonable option? | |
| How many patients might be identified & what follow-up would be necessary? – If the Safety Net is likely to identify a large number of patients, the importance of automated systems becomes more important (e.g., automated mailings to patients reminding them of labs) – If the number of patients identified is smaller, it may be feasible to have central review (e.g.. by a pharamcist or expert clinician) – In considering the capacity for follow-up, existing care processes and resources to resolve safety issues in a timely fashion are considered (e.g., care managers, automated direct mailings to patients | |
| Is anyone already working on addressing this safety issue? | |
The KPSC Outpatient Safety Net focuses on medication safety and diagnosis detection and follow-up. However, these are not listed among the criteria above because the Safety Net framework can be used to address a wide range of potential care gaps.
After quality gaps are identified, an intervention is required to resolve the quality gap in a timely fashion. These interventions have included: automated outreach to patients via mailed letter or Interactive Voice Recognition (IVR); notification of physicians with recommendations; use of case managers; use of pharmacists to review medications manually for flagged patients; batch order of lab tests with automated notification of the patient; and manual tracking and follow-up of other safety issues. “High volume” results require more automated solutions, or more staff, than “low volume” results; while there is no set definition for what constitutes high- versus low-volume issues, institutions will want to consider both the identification and resolution in assessing feasibility and solutions.